A review of the medical records of thousands of adolescents treated for obesity found that kids who received the GLP-1 ...

Retired Oak Ridge, Tennessee, physician notes the downside of a class of drugs − GLP-1s − first approved for treating ...

In response to rising demand for weight loss medications, WeightWatchers has launched a low-cost alternative to ...

MONDAY, Oct. 14, 2024 (HealthDay News) -- As with any new drug, parents and doctors may worry that the use of GLP-1 ...

A rapid-fire reversal from the Food and Drug Administration has injected even more uncertainty into what was already a wild ...

The FDA updated its database of drugs in shortage to remove tirzepatide, which had sat on that list – along with related ...

WW International, known as WeightWatchers, saw its stock soar on new of its new compounded GLP-1 offering. But analysts say ...

WeightWatchers (WW) is trying to save its ailing business by betting on a market that threatens its very existence. The ...

In addition to availability, the cost of weight loss drugs like Wegovy and Zepbound is a major barrier preventing many ...

When it comes to coverage for the pricey GLP-1 weight-loss drugs Wegovy and Zepbound, only a fifth of large U.S. companies ...

Fewer than 20% of large employers are covering GLP-1 weight loss drugs like Ozempic, a new KFF analysis shows.

WeightWatchers stock rises after the company announces compounded semaglutide offerings, addressing GLP-1 shortages while ...